Premium
Luteolin Inhibits Hyperglycemia‐Induced Proinflammatory Cytokine Production and Its Epigenetic Mechanism in Human Monocytes
Author(s) -
Kim Hye Joo,
Lee Wooje,
Yun JungMi
Publication year - 2014
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.5141
Subject(s) - luteolin , proinflammatory cytokine , cytokine , pharmacology , chemistry , biology , biochemistry , endocrinology , immunology , antioxidant , flavonoid , inflammation
Hyperglycemia is a key feature in diabetes. Hyperglycemia has been implicated as a major contributor to several complications of diabetes. High glucose levels induce the release of proinflammatory cytokines. Luteolin is a flavone isolated from celery, green pepper, perilla leaf, and chamomile tea. Luteolin has been reported to possess antimutagenic, antitumorigenic, antioxidant, and anti‐inflammatory properties. In this study, we investigated the effects of luteolin on proinflammatory cytokine secretion and its underlying epigenetic regulation in high‐glucose‐induced human monocytes. Human monocytic (THP‐1) cells were cultured under controlled (14.5 mM mannitol), normoglycemic (NG, 5.5 mM glucose), or hyperglycemic (HG, 20 mM glucose) conditions, in the absence or presence of luteolin. Luteolin (3–10 μM) was added for 48 h. While hyperglycemic conditions significantly induced histone acetylation, NF‐κB activation, and proinflammatory cytokine (IL‐6 and TNF‐α) release from THP‐1 cells, luteolin suppressed NF‐κB activity and cytokine release. Luteolin also significantly reduced CREB‐binding protein/p300 (CBP/p300) gene expression, as well as the levels of acetylation and histone acetyltransferase (HAT) activity of the CBP/p300 protein, which is a known NF‐κB coactivator. These results suggest that luteolin inhibits HG‐induced cytokine production in monocytes, through epigenetic changes involving NF‐κB. We therefore suggest that luteolin may be a potential candidate for the treatment and prevention of diabetes and its complications. Copyright © 2014 John Wiley & Sons, Ltd.